Bluspring Enter. (BLUSPRING)

FairStock Score: 10/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding at 58.24% strongly aligns insider and minority interests
• Piotroski F-Score of 7/9 indicates improving operational efficiency and financial health
• Debt/equity of 0.32 is conservative, limiting balance sheet risk
• Sales growth of 9.05% shows the business still has revenue momentum
• Price is near the 52-week low of ₹43.98 while book value is ₹46.02, so the downside is not extreme if earnings stabilize

Concerns

• Latest quarter net loss of ₹23 crore on sales of ₹863 crore; P/E of 0.00 reflects the absence of positive annual earnings
• ROCE of just 4.32% is far below what a value investor demands for capital deployed
• FairStock Score of 8/100 flags the stock as high-risk
• No dividend yield means minority shareholders receive no cash return while waiting for a recovery

AI Analysis

At ₹65.58, Bluspring has a market cap of ₹758 crore, but the first number I look for is missing—earnings. The latest quarter shows sales of ₹863 crore and a net loss of ₹23 crore, so the zero P/E is not a sign of cheapness; it is a sign that I cannot apply conventional valuation. Graham would say price is what you pay, value is what you get, and here the value is unclear. Book value is ₹46.02, so I am paying ₹65.58, or 1.43 times book, for a business earning a return on capital of only 4.32%. That is too low to create shareholder wealth. Despite the 9% sales growth, growth without profit is just topline vanity. The reported profit growth of 137% looks impressive, but it vanishes when the latest quarter still bleeds ₹23 crore. The debt-to-equity ratio of 0.32 is manageable, and a Piotroski score of 7/9 suggests recent financial health is improving. Promoter holding of 58.24% is aligned with minority shareholders, but no dividend means I earn nothing while I wait. The 52-week range of ₹43.98 to ₹131.60 tells me this stock has already disappointed many owners. I would need clear evidence—several consecutive profitable quarters, rising ROCE, and widening margins—before calling this a turnaround. Without a moat, with negative net profit, and with a FairStock score of 8/100, there is no margin of safety. I will keep it on my watchlist, not in my portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer